Literature DB >> 23306135

Equivalence of arterial and venous blood for [11C]CO2-metabolite analysis following intravenous administration of 1-[11C]acetate and 1-[11C]palmitate.

Yen Ng1, Steven P Moberly, Kieren J Mather, Clive Brown-Proctor, Gary D Hutchins, Mark A Green.   

Abstract

PURPOSE: Sampling of arterial blood for metabolite correction is often required to define a true radiotracer input function in quantitative modeling of PET data. However, arterial puncture for blood sampling is often undesirable. To establish whether venous blood could substitute for arterial blood in metabolite analysis for quantitative PET studies with 1-[(11)C]acetate and 1-[(11)C]palmitate, we compared the results of [(11)C]CO2-metabolite analyses performed on simultaneously collected arterial and venous blood samples.
METHODS: Paired arterial and venous blood samples were drawn from anesthetized pigs at 1, 3, 6, 8, 10, 15, 20, 25 and 30min after i.v. administration of 1-[(11)C]acetate and 1-[(11)C]palmitate. Blood radioactivity present as [(11)C]CO2 was determined employing a validated 10-min gas-purge method. Briefly, total blood (11)C radioactivity was counted in base-treated [(11)C]-blood samples, and non-[(11)C]CO2 radioactivity was counted after the [(11)C]-blood was acidified using 6N HCl and bubbled with air for 10min to quantitatively remove [(11)C]CO2.
RESULTS: An excellent correlation was found between concurrent arterial and venous [(11)C]CO2 levels. For the [(11)C]acetate study, the regression equation derived to estimate the venous [(11)C]CO2 from the arterial values was: y=0.994x+0.004 (r(2)=0.97), and for the [(11)C]palmitate: y=0.964x-0.001 (r(2)=0.9). Over the 1-30min period, the fraction of total blood (11)C present as [(11)C]CO2 rose from 4% to 64% for acetate, and 0% to 24% for palmitate. The rate of [(11)C]CO2 appearance in venous blood appears similar for the pig model and humans following i.v. [(11)C]-acetate administration.
CONCLUSION: Venous blood [(11)C]CO2 values appear suitable as substitutes for arterial blood samples in [(11)C]CO2 metabolite analysis after administration of [(11)C]acetate or [(11)C]palmitate ADVANCES IN KNOWLEDGE AND IMPLICATIONS FOR PATIENT CARE: Quantitative PET studies employing 1-[(11)C]acetate and 1-[(11)C]palmitate can employ venous blood samples for metabolite correction of an image-derived tracer arterial input function, thereby avoiding the risks of direct arterial blood sampling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306135      PMCID: PMC4620575          DOI: 10.1016/j.nucmedbio.2012.11.011

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  9 in total

1.  Synthesis and initial evaluation of 17-(11)C-heptadecanoic acid for measurement of myocardial fatty acid metabolism.

Authors:  T Lee Collier; Yuying Hwang; Ravichandran Ramasamy; Robert R Sciacca; Kathleen T Hickey; Norman R Simpson; Steven R Bergmann
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

Review 2.  Arterial catheterization.

Authors:  V L Clark; J A Kruse
Journal:  Crit Care Clin       Date:  1992-10       Impact factor: 3.598

3.  An automated SPE-based high-yield synthesis of [11C]acetate and [11C]palmitate: no liquid-liquid extraction, solvent evaporation or distillation required.

Authors:  Bruce H Mock; Clive Brown-Proctor; Mark A Green; Brandon Steele; Barbara E Glick-Wilson; Qi-Huang Zheng
Journal:  Nucl Med Biol       Date:  2011-08-09       Impact factor: 2.408

4.  Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Nucl Med       Date:  1989-02       Impact factor: 10.057

5.  Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.

Authors:  A F Shields; M M Graham; S M Kozawa; L B Kozell; J M Link; E R Swenson; A M Spence; J B Bassingthwaighte; K A Krohn
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

6.  Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction.

Authors:  M N Walsh; E M Geltman; M A Brown; C G Henes; C J Weinheimer; B E Sobel; S R Bergmann
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

7.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

8.  Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.

Authors:  K A Fox; D R Abendschein; H D Ambos; B E Sobel; S R Bergmann
Journal:  Circ Res       Date:  1985-08       Impact factor: 17.367

9.  Assessment of myocardial triglyceride oxidation with PET and 11C-palmitate.

Authors:  Zulfia Kisrieva-Ware; Andrew R Coggan; Terry L Sharp; Carmen S Dence; Robert J Gropler; Pilar Herrero
Journal:  J Nucl Cardiol       Date:  2009-02-11       Impact factor: 5.952

  9 in total
  7 in total

1.  Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.

Authors:  Kieren J Mather; Robert V Considine; LaTonya Hamilton; Niral A Patel; Carla Mathias; Wendy Territo; Adam G Goodwill; Johnathan D Tune; Mark A Green; Gary D Hutchins
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

Review 2.  Application of positron emission tomography in psychiatry-methodological developments and future directions.

Authors:  Simon Cervenka; Andreas Frick; Robert Bodén; Mark Lubberink
Journal:  Transl Psychiatry       Date:  2022-06-14       Impact factor: 7.989

3.  Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.

Authors:  K J Mather; G D Hutchins; K Perry; W Territo; R Chisholm; A Acton; B Glick-Wilson; R V Considine; S Moberly; T R DeGrado
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

4.  Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Authors:  Steven P Moberly; Kieren J Mather; Zachary C Berwick; Meredith K Owen; Adam G Goodwill; Eli D Casalini; Gary D Hutchins; Mark A Green; Yen Ng; Robert V Considine; Kevin M Perry; Robin L Chisholm; Johnathan D Tune
Journal:  Basic Res Cardiol       Date:  2013-06-14       Impact factor: 17.165

5.  Novel application of complementary imaging techniques to examine in vivo glucose metabolism in the kidney.

Authors:  Takashi Hato; Allon N Friedman; Henry Mang; Zoya Plotkin; Shataakshi Dube; Gary D Hutchins; Paul R Territo; Brian P McCarthy; Amanda A Riley; Kumar Pichumani; Craig R Malloy; Robert A Harris; Pierre C Dagher; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13

6.  Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET.

Authors:  Hiroki Kato; Tatsusada Okuno; Kayako Isohashi; Toru Koda; Mikito Shimizu; Hideki Mochizuki; Yuji Nakatsuji; Jun Hatazawa
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-13       Impact factor: 6.200

7.  Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [11C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism.

Authors:  Nana L Christensen; Steen Jakobsen; Anna C Schacht; Ole L Munk; Aage K O Alstrup; Lars P Tolbod; Hendrik J Harms; Søren Nielsen; Lars C Gormsen
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.